Archives of Orthopaedic and Trauma Surgery

, Volume 132, Issue 7, pp 1037–1044 | Cite as

Total hip replacement in patients with history of illicit injecting drug use

  • Karl Wieser
  • Patrick O. Zingg
  • Michael Betz
  • Georg Neubauer
  • Claudio Dora
Hip Arthroplasty



A history of illicit injecting drug use makes indication of total hip arthroplasty (THA) in patients with end stage hip osteoarthritis difficult, as the risk of infection with colonized strains is multiplied if the patient continues to inject or inhale illicit drugs.


A retrospective survivorship analysis of a consecutive series of 27 THA in patients with a history of illicit drug use was performed. Follow-up evaluation consisted of (1) a WOMAC score, (2) a standardized interview including queries on drug habits and eventual additional medico-surgical treatments of the affected hip, (3) a clinical examination in order to complete a Harris Hip Score, (4) radiological examination and (5) blood tests (blood sedimentation rates and C-reactive protein). Defined endpoints were death, implant revised or awaiting revision for deep infection or any other reason and lost to follow-up or follow-up after at least 2 years.


Overall, 5- and 10-year implant survival rates with failure for any reason were 61 % (CI: 41;81) and 52.3 % (CI: 29;76) and for septic reasons 70.6 % (CI: 52;89) and 60.5 % (CI: 36;85), respectively. Even if at the time of THA all patients and respective health care professionals confirmed abstinence of illicit injecting drug use, five patients reported occasional use. Declared abstinence of less than 1 year before THA was associated with higher recurrence rates (p = 0.001) and both with higher septic failure rates (p = 0.023, p = 0.061). Positive serology for human deficiency virus did not increase implant failure rates.


We use this unacceptable high failure rate as evidence when counseling patients and their health care professionals about the appropriate treatment of osteoarthritis in patients with a history of illicit drug use. Furthermore, we support the request of hair analysis for drugs documenting abstinence of at least 1 year before indicating THA.


Hip arthroplasty Survivorship analysis Illicit drug abuse 


  1. 1.
    European Monitoring Centre for Drugs and Drug Addiction (2010) Trends in injecting drug use in Europe. Publications office of the European Union, Luxembourg. ISBN:978-92-9168-412-0Google Scholar
  2. 2.
    Garfein RS, Vlahov D, Galai N, Doherty MC, Nelson KE (1996) Viral infections in short-term injection drug users: the prevalence of the hepatitis C, hepatitis B, human immunodeficiency, and human T-lymphotropic viruses. Am J Public Health 86:655–661PubMedCrossRefGoogle Scholar
  3. 3.
    March JC, Oviedo-Joekes E, Romero M (2007) Factors associated with reported hepatitis C and HIV among injecting drug users in ten European cities. Enferm Infecc Microbiol Clin 25:91–97PubMedCrossRefGoogle Scholar
  4. 4.
    Yombi JC, Vandercam B, Wilmes D, Dubuc JE, Vincent A, Docquier PL (2009) Osteonecrosis of the femoral head in patients with type 1 human immunodeficiency virus infection: clinical analysis and review. Clin Rheumatol 28:815–823PubMedCrossRefGoogle Scholar
  5. 5.
    Hensgens MP, Mudrikova TT, van der Meer JT (2009) Osteonecrosis as late complication in HIV-infected patients. Ned Tijdschr Geneeskd 153:B382PubMedGoogle Scholar
  6. 6.
    Eholié SP, Ouiminga M, Ehui E, Nzunetu G, Ouattara SI, Konan AV, Anglaret X, Bissagnéné E (2009) Avascular osteonecrosis of the femoral head in three West African HIV-infected adults with heterozygous sickle cell disease. Antivir Ther 14:1011–1014PubMedCrossRefGoogle Scholar
  7. 7.
    Lamas JL, Ocampo A, Martínez-Vázquez C, Miralles C, Longueira R, Arias M, Sopeña B, Rivera A, Portela D (2010) Asymptomatic osteonecrosis of the hip in HIV-infected patients. Enferm Infecc Microbiol Clin 28:150–155PubMedCrossRefGoogle Scholar
  8. 8.
    Gordon RJ, Lowy FD (2005) Bacterial infections in drug users. N Engl J Med 353:1945–1954PubMedCrossRefGoogle Scholar
  9. 9.
    Lowy FD, Miller M (2002) New methods to investigate infectious disease transmission and pathogenesis—Staphylococcus aureus disease in drug users. Lancet Infect Dis 2:605–612PubMedCrossRefGoogle Scholar
  10. 10.
    Gruen TA, McNeice GM, Amstutz HC (1979) “Modes of failure” of cemented stem-type femoral components: a radiographic analysis of loosening. Clin Orthop Relat Res 141:17–27PubMedGoogle Scholar
  11. 11.
    DeLee JG, Charnley J (1976) Radiological demarcation of cemented sockets in total hip replacement. Clin Orthop Relat Res 121:20–32PubMedGoogle Scholar
  12. 12.
    Hicks JL, Ribbans WJ, Buzzard B, Kelley SS, Toft L, Torri G, Wiedel JD, York J (2001) Infected joint replacements in HIV-positive patients with haemophilia. J Bone Joint Surg Br 83:1050–1054PubMedCrossRefGoogle Scholar
  13. 13.
    Parvizi J, Sullivan TA, Pagnano MW, Trousdale RT, Bolander ME (2003) Total joint arthroplasty in human immunodeficiency virus-positive patients: an alarming rate of early failure. J Arthroplasty 18:259–264PubMedCrossRefGoogle Scholar
  14. 14.
    Harrison WJ, Lavy CB, Lewis CP (2004) One-year follow-up of orthopaedic implants in HIV-positive patients. Int Orthop 28:329–332PubMedGoogle Scholar
  15. 15.
    Harrison WJ (2005) HIV/AIDS in trauma and orthopaedic surgery. J Bone Joint Surg Br 87:1178–1181PubMedCrossRefGoogle Scholar
  16. 16.
    Habermann B, Eberhardt C, Kurth AA (2008) Total joint replacement in HIV positive patients. J Infect 57:41–46PubMedCrossRefGoogle Scholar
  17. 17.
    Sendi P, Banderet F, Graber P, Zimmerli W (2011) Periprosthetic joint infection following Staphylococcus aureus bacteremia. J Infect 63:17–22PubMedCrossRefGoogle Scholar
  18. 18.
    Malinzak RA, Ritter MA, Berend ME, Meding JB, Olberding EM, Davis KE (2009) Morbidly obese, diabetic, younger, and unilateral joint arthroplasty patients have elevated total joint arthroplasty infection rates. J Arthroplasty 24:84–88PubMedCrossRefGoogle Scholar
  19. 19.
    Tomás T (2008) Patient-related risk factors for infected total arthroplasty. Acta Chir Orthop Traumatol Cech 75:451–456PubMedGoogle Scholar
  20. 20.
    Espehaug B, Havelin LI, Engesaeter LB, Langeland N, Vollset SE (1997) Patient-related risk factors for early revision of total hip replacements. A population register-based case-control study of 674 revised hips. Acta Orthop Scand 68:207–215PubMedCrossRefGoogle Scholar
  21. 21.
    Liniger B (2011) The value of laboratory analysis for general practitioners assessing fitness to drive of persons suspected problems with alcohol, illicit drugs or medicaments. Ther Umschau 68:265–268CrossRefGoogle Scholar
  22. 22.
    Balikova M (2005) Hair analysis for drugs of abuse. Plausibility of interpretation. Biomed Pap Med Cac Univ Palcky Olomouc Czech Repub 149:199–207Google Scholar

Copyright information

© Springer-Verlag 2012

Authors and Affiliations

  • Karl Wieser
    • 1
  • Patrick O. Zingg
    • 1
  • Michael Betz
    • 1
  • Georg Neubauer
    • 1
  • Claudio Dora
    • 1
  1. 1.Orthopaedic DepartmentBalgrist University Hospital, University of ZurichZurichSwitzerland

Personalised recommendations